Normalized Interferon Signatures and Clinical Improvements by IFNAR1 Blocking Antibody (anifrolumab) in Patients with Type I Interferonopathies.
JOURNAL OF CLINICAL IMMUNOLOGY(2025)
关键词
IFN-I,type I IFN,IFNAR1,Interferonopathies,Anifrolumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要